DBM is privileged to have a supportive Board of Directors.
Dr. Lawrence ‘Larry’ W. Greer, DDS, MBA is the Chair of the DBM Board of Directors. He is the senior managing partner at Greer Capital Advisors, a firm located in Birmingham, AL and charged with managing multiple investment funds including the Birmingham Technology Fund, the Scout Healthcare Fund, and multiple funds of the Alabama CapCo program. Larry was originally trained as a dentist; Larry had his own dental practice for over 10 years before deciding to learn more about the business and financial industries. After garnering an MBA at Emory and after working with Dunn Investments for several years, Larry founded Greer Capital Advisors, specializing in early-stage capital investment in life sciences and biotech.
Lawrence W. Greer, JD is a managing partner at Greer Capital Advisors and specializes in the legal considerations of deals being managed or considered by Greer Cap. Lawrence was a classmate of Dr. Schwiebert in the 2007 Entrepreneurial Accelerator Program sponsored by the Birmingham Venture Club. As of 2017, Lawrence now acts as the Chief Financial Officer for DBM.
Dr. Matthew ‘Matt’ A. Gonda, Ph.D. is the independent Board member for DBM. Matt is a ‘been there, done that’ CEO of multiple life science and biotechnology companies, most notably TransMolecular, Inc., where he raised over $30 million for the company while he was at the helm. Matt has been a key advisor to Dr. Schwiebert throughout DBM’s history from its inception to the present.
Dr. Erik Schwiebert, Ph.D. is a member of the DBM Board and Founder, CEO and CSO of DBM.